October 22, 2014 / 5:55 AM / in 5 years

BRIEF-Ipsen and Lexicon sign licensing and commercialization agreement for telotristat etiprate

Oct 22 (Reuters) - Ipsen SA :

* Lexicon Pharmaceuticals and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

* Ipsen to commercialize telotristat etiprate outside of North America and Japan

* Lexicon retains sole rights to commercialize telotristat etiprate in United States, Canada and Japan Source text for Eikon: Further company coverage: (Gdynia Newsroom: +48 58 698 39 20; Gdynia.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below